Position in ANRO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$97,847,707
+$14,497,330 QoQ
Shares Held
3,707,757
0.0% QoQ
Ownership
9.45%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#1
of 114 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alpha Wave Global, LP holds $118,365,065 across 2 Biotechnology names. ANRO ranks #1 (82.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANRO |
Alto Neuroscience, Inc.
This page
|
3,707,757 | $97,847,707 | |
| 2 | LENZ |
LENZ Therapeutics, Inc.
|
3,612,211 | $20,517,358 |
All Filings in ANRO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,847,707 | 3,707,757 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $83,350,377 | 3,707,757 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $65,998,074 | 3,707,757 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,905,183 | 3,707,757 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,157,065 | 3,707,757 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,008,755 | 3,707,757 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,683,812 | 3,707,757 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $42,416,740 | 3,707,757 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,635,922 | 3,707,757 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $56,914,069 | 3,707,757 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||